Index Entries - Covid Index

1160 Results

Title	IS Publication Date
Reply to Fung et al. on COVID‐19 vaccine case‐countingwindow biases overstating vaccine effectiveness	July 4, 2023
Report an Adverse Event to VAERS
Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and Sweden	August 19, 2024
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States	February 1, 2023
Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities	March 30, 2021
Research Letter: Acute Allergic Reactions to mRNA COVID-19 Vaccines	March 8, 2021
Research Letter: Age- and Sex-Specific Incidence of Cerebral Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination	November 1, 2021
Research Letter: All-Cause Excess Mortality and COVID-19 - Related Mortality Among US Adults Aged 25-44 Years, March-July 2020	December 16, 2020
Research Letter: Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy	May 28, 2021
Research Letter: Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk	September 26, 2022
Research Letter: Routine Surveillance and Vaccination on a University Campus During the Spread of the SARS-CoV-2 Omicron Variant	May 18, 2022
Responding to Covid‐19: How to Navigate a Public Health Emergency Legally and Ethically	March 26, 2020
Response to Request for Information (RFI): COVID-19 Misinformation from Official Sources During the Pandemic	May 2, 2022
Response: Ed Humpherson to Norman Fenton, Martin Neil, Clare Craig and Scott McLachlan: ONS Deaths by Vaccination Status statistics	January 23, 2023
Results of a systematic review and meta‑analysis of early studies on ivermectin in SARS‑CoV‑2 infection	March 7, 2023
Results of an Open Prospective Controlled Comparative Study on the Treatment of Novel Coronavirus Infection (COVID-19): Bromhexine & Spironolactone for the Treatment of Coronavirus Infection Requiring Hospitalization	May 11, 2020
Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro	February 23, 2021
Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues	May 25, 2021
Reversible cerebral vasoconstriction syndrome and posterior reversible encephalopathy syndrome following vaccination: analysis of the VAERS database and systematic review	October 18, 2023
Review of COVID-19 Vaccines and the Risk of Chronic Adverse Events Including Neurological Degeneration	March 24, 2021
Review of scientific reports of harms caused by face masks, up to February 2021	February 22, 2021
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19	April 22, 2021
Revisiting Pediatric COVID-19 Cases in Counties With and Without School Mask Requirements—United States, July 1—October 20 2021	May 25, 2022
Risk assessment of retinal vascular occlusion after COVID-19 vaccination	May 2, 2023
Risk of Coronavirus Disease 2019 (COVID-19) among those up-to-date and not up-to-date on COVID-19 vaccination by US CDC criteria	November 8, 2023
Risk of Hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS -CoV-2 infection in Germany	November 30, 2021
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden	February 4, 2022
Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England	June 7, 2023
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination	August 19, 2022
Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis	June 20, 2023
Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods	April 11, 2022
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia	November 21, 2023
Risk of severe COVID-19 infection among adults with prior exposure to children	July 27, 2022
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study	August 26, 2021
Risks of Covid-19 face masks to wildlife: Present and future research needs	October 20, 2021
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection	December 14, 2021
Roadmap for the Implementation of Actions by the European Commission based on the Commission Communication and the Council Recommendation on Strengthening Cooperation against Vaccine Preventable Diseases	Last update Q3 2019
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months	December 4, 2020
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection	March 5, 2021
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19	August 14, 2020
Rochelle Walensky on the risk of COVID-19 vaccines for 12-17 year olds	June 24, 2021
Role of hydroxychloroquine in multidrug treatment of COVID-19	September 24, 2021
Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study	February 16, 2021
Rush to Use Ventilators Killed Thousands of COVID Patients	September 18, 2024
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months	November 4, 2021
Safety and Health Guidance: COVID-19 Infection Prevention for Logistics Employers and Employees	October 27, 2020
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data	February 26, 2024
Safety of mRNA Vaccines Administered During the First Twenty-Four Months of the International COVID-19 Vaccination Program	April 10, 2023
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting	September 16, 2021

Page 17 of 24